Related Experiment Video
Updated: Jun 15, 2026

06:45
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous thromboembolism: no longer a silent killer
1Portsmouth Hospitals NHS Trust.
Summary
Up to 80% of fatal venous thromboembolism events are silent. Nurses must familiarize themselves with new National Institute for Health and Care Excellence (NICE) guidelines to reduce the risk of these dangerous blood clots.
Area of Science:
- Medical Science
- Nursing Practice
- Public Health
Background:
- Venous thromboembolism (VTE) is a significant cause of preventable death.
- A high percentage of VTE deaths occur without warning symptoms, highlighting a critical gap in detection and prevention.
- Current clinical practice necessitates updated guidance for effective risk reduction.
Purpose of the Study:
- To emphasize the critical need for nurses to understand and implement the latest NICE guidelines on VTE risk reduction.
- To raise awareness about the silent nature of many fatal VTE events.
- To advocate for improved nursing knowledge and application of VTE prevention strategies.
Main Methods:
- Review and dissemination of the new NICE guidelines for Venous thromboembolism--reducing the risk.
- Educational emphasis on recognizing subtle or absent VTE symptoms.
- Promoting adherence to evidence-based VTE prevention protocols within nursing practice.
Main Results:
- Nurses require updated knowledge on VTE risk factors and prevention.
- The "silent" nature of VTE necessitates proactive screening and intervention.
- Adherence to NICE guidelines can significantly mitigate VTE-related mortality.
Conclusions:
- Familiarity with and application of the NICE guidelines are essential for all nurses.
- Proactive nursing interventions based on updated guidelines are crucial for reducing silent VTE deaths.
- Enhancing nursing awareness and practice is key to improving patient outcomes in VTE prevention.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
